mRNA COVID-19 Vaccines and Their Risk to Induce a Relapse of Glomerular Diseases.

Kronbichler, Andreas; Anders, Hans-Joachim

Kronbichler, Andreas; Anders, Hans-Joachim.

Kronbichler A; Department of Medicine, University of Cambridge, Cambridge, United Kingdom ak2283@cam.ac.uk.
Anders HJ; Renal Division, Department of Medicine IV, Hospital of the Ludwig Maximilian University, Munich, Germany.

J Am Soc Nephrol ; 33(12): 2128-2131, 2022 Dec.

Article in English | MEDLINE | ID: covidwho-2109464

Subject(s)

COVID-19; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Kidney Diseases; Lupus Nephritis; Humans; COVID-19 Vaccines/adverse effects; RNA, Messenger; COVID-19/prevention & control; Recurrence; Biopsy

Keywords

COVID-19; IgA nephropathy; focal segmental glomerulosclerosis; glomerular disease; lupus nephritis; membranous nephropathy; vasculitis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lupus Nephritis / Glomerulosclerosis, Focal Segmental / Glomerulonephritis, Membranous / COVID-19 / Glomerulonephritis / Glomerulonephritis, IGA / Kidney Diseases Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: J Am Soc Nephrol Journal subject: Nephrology Year: 2022 Document Type: Article Affiliation country: Asn.2022091078

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google